期刊文献+

益气复元合剂联合常规药物在急性心肌梗死经皮冠状动脉介入术术后患者中的应用效果

Effect of Yiqi Fuyuan Mixture Combined with Conventional Drugs in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:探讨益气复元合剂联合常规药物在急性心肌梗死经皮冠状动脉介入术(PCI)术后患者中的应用效果。方法:选取2022年4—12月广州市中西医结合医院收治的急性心肌梗死PCI术后患者120例作为研究对象,按照随机数字表法分为对照组和研究组,各60例。对照组给予常规药物治疗,研究组在对照组基础上给予益气复元合剂治疗。比较两组治疗效果。结果:研究组治疗总有效率高于对照组,差异有统计学意义(P=0.048)。治疗前,两组中医症状积分比较,差异无统计学意义(P>0.05);治疗后,研究组胸痛、胸闷、心悸气短以及神倦乏力积分均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05)。治疗后,两组心理、生理、社会关系、环境评分均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05)。结论:益气复元合剂联合常规药物在急性心肌梗死PCI术后患者中的应用效果显著,可促进患者症状改善,提升生活质量。 Objective:To investigate the effect of Yiqi Fuyuan mixture combined with conventional drugs in patients with acute myocardial infarction after percutaneous coronary intervention(PCI).Methods:A total of one hundred and twenty patients with acute myocardial infarction after PCI treated in Guangzhou Hospital of Integrated Chinese and Western Medicine from April 2022 to December 2022 were selected as the study objects,and were divided into control group and study group according to random number table method,with sixty cases in each group.The control group was given conventional drug treatment,and the study group was given Yiqi Fuyuan mixture on the basis of the control group.The therapeutic effect of the two groups was compared.Results:The total effective rate of the study group was higher than that of the control group,the difference was statistically significant(P=0.048);Before treatment,there was no significant difference in TCM symptom score between the two groups(P>0.05);After treatment,the scores of chest pain,chest tightness,palpitation and shortness of breath in the study group were lower than before treatment,and the scores of the study group were lower than those of the control group,the difference was statistically significant(P<0.05);After treatment,the scores of psychological,physiological,social relationship and environment in both groups were higher than before treatment,and the study group was higher than the control group,the difference was statistically significant(P<0.05).Conclusion:The effect of Yiqi Fuyuan mixture combined with conventional drugs in patients with acute myocardial infarction after PCI can promote the improvement of patients'symptoms and improve their quality of life.
作者 吴国宝 聂鹏飞 叶少强 吴永刚 王锐 Wu Guobao;Nie Pengfei;Ye Shaoqiang;Wu Yonggang;Wang Rui(Department of Cardiology,Guangzhou Hospital of Integrated Traditional Chinese and Western Medicine,Guangzhou 510800,Guangdong Province,China)
出处 《中外医药研究》 2023年第27期96-98,共3页 JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
基金 广州市花都区科技计划项目(编号:HDWS-090)。
关键词 益气复元合剂 急性心肌梗死 经皮冠状动脉介入术 生活质量 Yiqi Fuyuan mixture Acute myocardial infarction Percutaneous coronary intervention Quality of life
  • 相关文献

参考文献9

二级参考文献96

  • 1夏霓,程翔.心肌缺血再灌注损伤的免疫学机制研究进展[J].中国医学前沿杂志(电子版),2013,5(4):42-47. 被引量:3
  • 2高铸烨,徐浩,史大卓,史载祥,周雪忠.急性心肌梗死中医辨证分型的聚类研究[J].中国中医急症,2007,16(4):432-434. 被引量:33
  • 3Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
  • 4Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
  • 5Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
  • 6Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
  • 7Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
  • 8Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
  • 9Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
  • 10Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.

共引文献5424

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部